Abstract
The abnormal aggregation of amyloid β-protein (Aβ) is considered to be central in the pathogenesis of Alzheimer's disease. We have focused on ‘membrane-mediated’ amyloidogenesis because Yanagisawa et al. identified a specific form of Aβ that was bound to monosialoganglioside GM1 in brains exhibiting the early pathological changes associated with the disease. We have found that amyloid fibrils formed on GM1 clusters were more toxic than those formed in solution [1, 2]. The less toxic fibrils formed in solution are considered to be composed of in-resister parallel β-sheets, whereas the structure of the toxic fibrils is unknown, although FTIR spectra suggested the presence of antiparallel β-sheets [1, 2].In this study, we investigated the structure of the toxic fibrils in detail. Solid-state NMR measurements using site-specifically [15N, 1-13C]-labeled Aβs suggested that the fibrils contained both parallel and antiparallel β-sheet structures. Chemical cross-linking experiments using Cys-substituted Aβs also supported this conclusion. Thus, the toxic fibrils were found to possess a novel unique structure.[1] Fukunaga, S. et al., Biochemistry 51, 8125 (2012).[2] Matsuzaki, K., Acc. Chem. Res. 47, 2397 (2014).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.